These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3121595)

  • 1. The heparin binding site of human antithrombin III. Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity.
    Liu CS; Chang JY
    J Biol Chem; 1987 Dec; 262(36):17356-61. PubMed ID: 3121595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine residues are critical for the heparin-cofactor activity of antithrombin III.
    Jorgensen AM; Borders CL; Fish WW
    Biochem J; 1985 Oct; 231(1):59-63. PubMed ID: 4062892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin III.
    Sun XJ; Chang JY
    Biochemistry; 1990 Sep; 29(38):8957-62. PubMed ID: 2271571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of heparin to human antithrombin III activates selective chemical modification at lysine 236. Lys-107, Lys-125, and Lys-136 are situated within the heparin-binding site of antithrombin III.
    Chang JY
    J Biol Chem; 1989 Feb; 264(6):3111-5. PubMed ID: 2492530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.
    Pecon JM; Blackburn MN
    J Biol Chem; 1984 Jan; 259(2):935-8. PubMed ID: 6420409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
    Schedin-Weiss S; Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 2002 Oct; 41(41):12369-76. PubMed ID: 12369826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of lysine 125 for heparin binding and activation of antithrombin.
    Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
    Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III.
    Kridel SJ; Chan WW; Knauer DJ
    J Biol Chem; 1996 Aug; 271(34):20935-41. PubMed ID: 8702852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function relationships in heparin cofactor II: chemical modification of arginine and tryptophan and demonstration of a two-domain structure.
    Church FC; Villanueva GB; Griffith MJ
    Arch Biochem Biophys; 1986 Apr; 246(1):175-84. PubMed ID: 3754413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of chemical modification of tryptophan residues on the properties of human antithrombin III.
    Shah N; Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1990 Feb; 57(3):343-52. PubMed ID: 2315891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin binding domain of human antithrombin III inferred from the sequential reduction of its three disulfide linkages. An efficient method for structural analysis of partially reduced proteins.
    Sun XJ; Chang JY
    J Biol Chem; 1989 Jul; 264(19):11288-93. PubMed ID: 2544589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a lysyl residue in antithrombin which is essential for heparin binding.
    Peterson CB; Noyes CM; Pecon JM; Church FC; Blackburn MN
    J Biol Chem; 1987 Jun; 262(17):8061-5. PubMed ID: 3110143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A heparin binding site in antithrombin III. Identification, purification, and amino acid sequence.
    Smith JW; Knauer DJ
    J Biol Chem; 1987 Sep; 262(25):11964-72. PubMed ID: 3305499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refolding properties of antithrombin III. Mechanism of binding to heparin.
    Villanueva GB; Allen N
    J Biol Chem; 1983 Nov; 258(22):14048-53. PubMed ID: 6643466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictions of the secondary structure of antithrombin III and the location of the heparin-binding site.
    Villanueva GB
    J Biol Chem; 1984 Feb; 259(4):2531-6. PubMed ID: 6698980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site.
    Skinner R; Abrahams JP; Whisstock JC; Lesk AM; Carrell RW; Wardell MR
    J Mol Biol; 1997 Feb; 266(3):601-9. PubMed ID: 9067613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of arginine 132 and lysine 133 in heparin binding to and activation of antithrombin.
    Meagher JL; Huntington JA; Fan B; Gettins PG
    J Biol Chem; 1996 Nov; 271(46):29353-8. PubMed ID: 8910598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.